N-methoxy rocaglamide
has antineoplastic activity; inhibits eukaryotic initiation factor 4A (eIF4A)-dependent mRNA translation initiation
Also Known As:
(+) N-methoxy rocaglamide; (+)-CR-31-B; (+-) N-methoxy rocaglamide; (+-)-CR-31-B; (-) N-methoxy rocaglamide; (-)-CR-31-B; CR-31-B; CR-31-B (+); CR-31-B (+-); CR-31-B (-); N-methoxyrocaglamide
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Elgner, Fabian:
1 article
(01/2020)
|
| 2. | Glitscher, Mirco:
1 article
(01/2020)
|
| 3. | Grünweller, Arnold:
1 article
(01/2020)
|
| 4. | Hartmann, Roland K:
1 article
(01/2020)
|
| 5. | Hildt, Eberhard:
1 article
(01/2020)
|
| 6. | Lange-Grünweller, Kerstin:
1 article
(01/2020)
|
| 7. | Müller, Christin:
1 article
(01/2020)
|
| 8. | Obermann, Wiebke:
1 article
(01/2020)
|
| 9. | Oestereich, Lisa:
1 article
(01/2020)
|
| 10. | Schulte, Falk W:
1 article
(01/2020)
|